RCT_Cheng 2003
Trial name or title | Selenium Supplementation for the Prevention of Hepatocellular Carcinomas in HBsAg Positive Patients (pilot study) |
Methods | Randomised controlled trial |
Participants | Men 45 to 64 years of age with positive HBsAg test, negative AFP test and normal ALT values |
Interventions | Placebo or 200 mg (sic!)/d selenium as selenised yeast |
Outcomes | Primary liver cancer |
Starting date | 2003 |
Contact information | Prof Kar Keung Cheng, University of Birmingham, UK |
Notes | Study author contacted for further information, but no reply received Should probably say 200 µg/d selenium yeast as intervention in the publication |